To include your compound in the COVID-19 Resource Center, submit it here.

CRLX301: Phase I data

Data from 20 patients with advanced solid tumors in the Phase I portion of an open-label, international Phase

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE